IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Aqualis acquires Norwegian API producer Weifa

9:37 AM MDT | June 17, 2014 | Deepti Ramesh

Aqualis (Oslo) announced on 17 June that it has entered into a definitive share purchase agreement with Weifa Holding to acquire all of the shares in Weifa (Oslo), a leading, fully-integrated pharmaceutical company in Norway and a major supplier of active pharmaceutical ingredients (APIs) to the international pharmaceutical industry, for 1.1 billion Norwegian kroner ($184 million). Aqualis is involved in the marine and offshore and health-care businesses. Weifa is a market leader within the consumer health pain-relief segment and a leading supplier of APIs for...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa